Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page
- Check5 days agoChange DetectedThe recruitment status on the page was updated to show that enrollment is closed (No longer looking for participants), clarifying that the study is not accepting new participants.SummaryDifference0.4%

- Check12 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new build of the page rather than a substantive change to the study details.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.4 was added, replacing Revision: v3.5.3. This indicates a small system/UI update and does not modify study details.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or platform update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.